Intranasal Immunization with Live Recombinant Lactococcus lactis Combined with Heat-Labile Toxin B Subunit Protects Chickens from Highly Pathogenic Avian Influenza H5N1 Virus
Intranasal Immunization with Live Recombinant Lactococcus lactis Combined with Heat-Labile Toxin B Subunit Protects Chickens from Highly Pathogenic Avian Influenza H5N1 Virus
复制标题
使用活重组乳酸乳球菌结合不耐热毒素 B 亚基进行鼻内免疫可保护鸡免受高致病性禽流感 H5N1 病毒的侵害。
DOI:
10.1002/jmv.23983
复制
发表时间:
2015-01-01
影响因子:
12.7
通讯作者:
Zhao, Daxian
中科院分区:
文献类型:
--
作者:
Lei, Han;Peng, Xiaojue;Zhao, Daxian
Development of safe and effective vaccines to prevent highly pathogenic avian influenza H5N1 virus infection is a challenging goal. Lactococcus lactis (L. lactis) is an ideal delivery vector for vaccine development, and it has been shown previously that oral immunization of encapsulated secretory L. lactis-hemagglutinin (HA) could provide complete protection against homologous H5N1 virus challenge in the mice model. While intranasal immunization is an appealing approach, it is now reported that secretory L. lactis-HA combined with mucosal adjuvant heat-labile toxin B subunit (LTB) could provide protective immunity in the chicken model. As compared to intranasal immunization with L. lactis-HA alone, L. lactis-HA combined with LTB (L. lactis-HA+LTB) could elicit robust neutralizing antibody responses and mucosal IgA responses, as well as strong cellular immune responses in the vaccinated chickens. Importantly, intranasal immunization with L. lactis-HA+LTB could provide 100% protection against H5N1 virus challenge. Taken together, these results suggest that intranasal immunization with L. lactis-HA+LTB can be considered as an effective approach for preventing and controlling infection of H5N1 virus in poultry during an avian influenza A/H5N1 pandemic. J. Med. Virol. 87: 39-44, 2015. (c) 2014 Wiley Periodicals, Inc.